A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents

E-ISSN： 1600-0609|94|2|145-151

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.2, 2015-02, pp. : 145-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extramedullary disease in multiple myeloma in the era of novel agents

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 763-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

Acta Haematologica, Vol. 132, Iss. 2, 2014-03 ,pp. : 211-219

Karger

Access to resources Recommend Favorite

Real‐world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 269-4727, Iss. 1, 2013-02 ,pp. : 41-47

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real‐world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 38, Iss. 1, 2013-02 ,pp. : 41-47

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients

Oncology Research and Treatment, Vol. 40, Iss. 10, 2017-09 ,pp. : 616-620

Karger

Access to resources Recommend Favorite